Funds holding Monte Rosa Therapeutics Inc
211 funds declare a position · 47 ETFs and 164 other funds · 387.2M $ · US61225M1027
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 201 | PROFUND VP ULTRA SMALL CAP ProFunds | 202 | 3.3K $ | 0.02 % | as of Mar 31, 2026 · Original filing |
| 202 | PROFUND VP SMALL CAP ProFunds | 153 | 2.5K $ | 0.02 % | as of Mar 31, 2026 · Original filing |
| 203 | Russell 2000 Fund Rydex Series Funds | 136 | 2.2K $ | 0.02 % | as of Mar 31, 2026 · Original filing |
| 204 | SMALL-CAP PROFUND ProFunds | 110 | 2.1K $ | 0.03 % | as of Apr 30, 2026 · Original filing |
| 205 | Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 107 | 1.8K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 206 | Russell 2000 1.5x Strategy Fund Rydex Series Funds | 82 | 1.3K $ | 0.02 % | as of Mar 31, 2026 · Original filing |
| 207 | ProShares Hedge Replication ETF ProShares Trust | 48 | 852 $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 208 | Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 39 | 641.6 $ | 0.02 % | as of Mar 31, 2026 · Original filing |
| 209 | ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 14 | 248.5 $ | 0.02 % | as of Feb 28, 2026 · Original filing |
| 210 | Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 13 | 213.9 $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 211 | Longview Advantage ETF RBB Fund Trust | 6 | 106.5 $ | as of Feb 28, 2026 · Original filing |
Institutional managers
182 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| NEA Management Company, LLC | 7,692,298 | 126.5M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,637,684 | 92.7M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 4,622,151 | 76M $ | as of Mar 31, 2026 |
| BVF INC/IL | 4,460,886 | 73.4M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 4,345,736 | 71.5M $ | as of Mar 31, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,226,809 | 69.5M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 3,603,465 | 59.3M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,353,980 | 55.2M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 3,206,574 | 52.7M $ | as of Mar 31, 2026 |
| Versant Venture Management, LLC | 3,180,780 | 52.3M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 2,809,647 | 46.2M $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,002,040 | 32.9M $ | as of Mar 31, 2026 |
| Aisling Capital Management LP | 1,555,664 | 25.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,540,812 | 25.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,433,152 | 23.6M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 1,250,000 | 20.6M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 1,176,928 | 19.4M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,041,372 | 17.1M $ | as of Mar 31, 2026 |
| FMR LLC | 1,024,304 | 16.8M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,001,527 | 16.5M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 1,000,000 | 16.5M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 826,624 | 13.6M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 685,926 | 11.3M $ | as of Mar 31, 2026 |
| Alphabet Inc. | 684,275 | 11.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 684,063 | 11.3M $ | as of Mar 31, 2026 |